Skip to main content
Log in

Continuation of vitamin K antagonists as acceptable anticoagulation regimen in patients undergoing pulmonary vein isolation

  • Original article
  • Published:
Netherlands Heart Journal Aims and scope Submit manuscript

Abstract

Background

Recent studies have demonstrated that radiofrequency isolation of the pulmonary veins (PVI) is an effective treatment for symptomatic atrial fibrillation. Based on these positive results, non- pharmacological therapy has been incorporated in the guidelines for drug refractory atrial fibrillation, resulting in an increased popularity. The prevention of thromboembolic complications remains an important issue.

Methods

In January 2010, we adopted an anticoagulation strategy based on continuation of vitamin K antagonists (VKAs) and selective use of transoesophageal echocardiogram (TEE). We retrospectively analysed the results of this strategy in all patients referred for PVI treatment. VKAs were started for all patients 2 months prior to treatment. Discontinuation of oral anticoagulation was considered 3 months after treatment based on thromboembolic and bleeding risk profile. Bleeding and thromboembolic complications were registered during outpatient clinic follow-up up until 3 months.

Results

We performed 151 PVI procedures from January 2010 to March 2011. All patients were seen 6 weeks after discharge. No transient ischaemic accidents or ischaemic cerebrovascular incidents occurred pre-, peri- or postprocedure. Four (2.7%) procedures were complicated by tamponade requiring pericardiocentesis.

Conclusions

Our data support the increasing evidence for continuation of periprocedural administration of VKAs complemented by a selective TEE approach as a safe therapy for thromboembolic complications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339:659–66.

    Article  PubMed  CAS  Google Scholar 

  2. Jais P, Cauchemez B, Macle L, et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation. 2008;118:2498–505.

    Article  PubMed  Google Scholar 

  3. Cappato R, Calkins H, Chen SA, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3:32–8.

    Article  PubMed  Google Scholar 

  4. Gopinath D, Lewis WR, Biase LD. Pulmonary vein antrum isolation for atrial fibrillation on therapeutic Coumadin: special considerations. J Cardiovasc Electrophysiol. 2011;22:236–9.

    PubMed  Google Scholar 

  5. Nazeri A, Rasekh A, Massumi A, et al. Coalescence of splines on a basket mapping catheter during ablation using a closed-loop irrigation catheter. Europace. 2009;11:258–9.

    Article  PubMed  Google Scholar 

  6. Demolin JM, Eick OJ, Munch K, et al. Soft thrombus formation in radiofrequency catheter ablation. Pacing Clin Electrophysiol. 2002;25:1219–22.

    Article  PubMed  Google Scholar 

  7. Oral H, Chugh A, Ozaydin M, et al. Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation. 2006;114:759–65.

    Article  PubMed  Google Scholar 

  8. Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31:2369–429.

    Article  PubMed  Google Scholar 

  9. Muller A, Scharner W, Borchardt T, et al. Reliability of an external loop recorder for automatic recognition and transtelephonic ECG transmission of atrial fibrillation. J Telemed Telecare. 2009;15:391–6.

    Article  PubMed  Google Scholar 

  10. Calkins H, Brugada J, Packer DL, et al. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) task force on catheter and surgical ablation of atrial fibrillation. Hear Rhythm. 2007;4:816–61.

    Article  Google Scholar 

  11. Calvo N, Mont L, Vidal B, et al. Usefulness of transoesophageal echocardiography before circumferential pulmonary vein ablation in patients with atrial fibrillation: is it really mandatory? Europace. 2011;13:486–91.

    Article  PubMed  CAS  Google Scholar 

  12. Puwanant S, Varr BC, Shrestha K, et al. Role of the CHADS2 score in the evaluation of thromboembolic risk in patients with atrial fibrillation undergoing transesophageal echocardiography before pulmonary vein isolation. J Am Coll Cardiol. 2009;54:2032–9.

    Article  PubMed  Google Scholar 

  13. Grip L, Blomback M, Schulman S. Hypercoagulable state and thromboembolism following warfarin withdrawal in post-myocardial-infarction patients. Eur Heart J. 1991;12:1225–33.

    Article  PubMed  CAS  Google Scholar 

  14. Gaita F, Caponi D, Pianelli M, et al. Radiofrequency catheter ablation of atrial fibrillation: a cause of silent thromboembolism? Magnetic resonance imaging assessment of cerebral thromboembolism in patients undergoing ablation of atrial fibrillation. Circulation. 2010;122:1667–73.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. F. Scholten.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oude Velthuis, B., Stevenhagen, J., van Opstal, J.M. et al. Continuation of vitamin K antagonists as acceptable anticoagulation regimen in patients undergoing pulmonary vein isolation. Neth Heart J 20, 12–15 (2012). https://doi.org/10.1007/s12471-011-0223-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12471-011-0223-0

Keywords

Navigation